Covid-19 Research

Case Report

OCLC Number/Unique Identifier: 9041827397

Langerhans Cell Histiocytosis of the Right Scapula

General Science    Start Submission

Meisam Moradi, Sepideh Babaniamansour, Mohammadreza Majidi, Sepideh Karkon-Shayan, Mohammad Dehghani Firouzabadi and Ahmadreza Atarodi*

Volume2-Issue4
Dates: Received: 2021-03-19 | Accepted: 2021-04-12 | Published: 2021-04-13
Pages: 268-271

Abstract

Langerhans Cell Histiocytosis (LCH) is a rare granulomatous disease with an unknown origin. LCH occurs at any age and affects any organ. It is presented as self-limited to aggressive forms. Late diagnosis of LCH, after the evidence is revealed at the radiological imaging or microscopic investigations, aggravates the possible complications. This study reported a rare case of LCH with a bone lytic lesion at the right scapula with a good prognosis.

FullText HTML FullText PDF DOI: 10.37871/jbres1223


Certificate of Publication




Copyright

© 2021 Moradi M, et al. Distributed under Creative Commons CC-BY 4.0

How to cite this article

Moradi M, Babaniamansour S, Majidi M, Karkon-Shayan S, Firouzabadi MD, Atarodi A. Langerhans Cell Histiocytosis of the Right Scapula. J Biomed Res Environ Sci. 2021 Apr 13; 2(4): 268-271. doi: 10.37871/jbres1223, Article ID: jbres1223


Subject area(s)

References


  1. da Costa CE, Egeler RM, Hoogeboom M, Szuhai K, Forsyth RG, Niesters M, de Krijger RR, Tazi A, Hogendoorn PC, Annels NE. Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease. J Pathol. 2007 Jun;212(2):188-97. doi: 10.1002/path.2167. PMID: 17447723.
  2. Makras P, Polyzos SA, Anastasilakis AD, Terpos E, Papatheodorou A, Kaltsas GA. Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis? Mol Ther. 2012 Jan;20(1):6-7. doi: 10.1038/mt.2011.239. PMID: 22215051; PMCID: PMC3255574.
  3. Rizzo FM, Cives M, Simone V, Silvestris F. New insights into the molecular pathogenesis of langerhans cell histiocytosis. Oncologist. 2014 Feb;19(2):151-63. doi: 10.1634/theoncologist.2013-0341. Epub 2014 Jan 16. PMID: 24436311; PMCID: PMC3926789.
  4. Nakamura T, Morimoto N, Goto F, Shioda Y, Hoshino H, Kubota M, Taiji H. Langerhans cell histiocytosis with disequilibrium. Auris Nasus Larynx. 2012 Dec;39(6):627-30. doi: 10.1016/j.anl.2012.01.003. Epub 2012 Feb 10. PMID: 22326120.
  5. Babaniamansour S, Aliniagerdroudbari E, Niroomand M. Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study. J Diabetes Metab Disord. 2020 Jul 8;19(2):933-940. doi: 10.1007/s40200-020-00583-4. PMID: 33520813; PMCID: PMC7843766.
  6. Gabbay LB, Leite Cda C, Andriola RS, Pinho Pda C, Lucato LT. Histiocytosis: a review focusing on neuroimaging findings. Arq Neuropsiquiatr. 2014 Jul;72(7):548-58. doi: 10.1590/0004-282x20140063. PMID: 25054989.
  7. Van’t Hooft I, Gavhed D, Laurencikas E, Henter JI. Neuropsychological sequelae in patients with neurodegenerative Langerhans cell histiocytosis. Pediatr Blood Cancer. 2008 Nov;51(5):669-74. doi: 10.1002/pbc.21656. PMID: 18623210.
  8. Babaniamansour P, Mohammadi M, Babaniamansour S, Aliniagerdroudbari E. The Relation between Atherosclerosis Plaque Composition and Plaque Rupture. J Med Signals Sens. 2020 Nov 11;10(4):267-273. doi: 10.4103/jmss.JMSS_48_19. PMID: 33575199; PMCID: PMC7866947.
  9. Aricò M, Nichols K, Whitlock JA, Arceci R, Haupt R, Mittler U, Kühne T, Lombardi A, Ishii E, Egeler RM, Danesino C. Familial clustering of Langerhans cell histiocytosis. Br J Haematol. 1999 Dec;107(4):883-8. doi: 10.1046/j.1365-2141.1999.01777.x. PMID: 10606898.
  10. Tsirakis G, Kaparou M, Kanellou P, Kontakis G, Alexandrakis M. Langerhans cell histiocytosis in the right scapula in a young man. International Journal of Case Reports and Images. 2012;3:16. https://bit.ly/2PNkUXh
  11. Yoon JH, Park HJ, Park SY, Park BK. Langerhans cell histiocytosis in non-twin siblings. Pediatr Int. 2013 Jun;55(3):e73-6. doi: 10.1111/ped.12034. PMID: 23782385.
  12. Pandey R, Bhayana H, Rajnish R, Dhammi I, Jain A, Haq R-U. Langerhans cell histiocytosis of the scapula-diagnosis & treatment options. Coluna/Columna. 2017;16:240-3. https://bit.ly/3a426d6
  13. Sayyahfar S, Ansari S, Rahbar M, Zarei E. Langerhans cell histiocytosis of the clavicle in a 10-years-old girl. Iranian journal of Pediatric Hematology and Oncology. 2017;7(4):260-263. https://bit.ly/3mEE2Cu
  14. Udaka T, Susa M, Kikuta K, Nishimoto K, Horiuchi K, Sasaki A, Kameyama K, Nakamura M, Matsumoto M, Chiba K, Morioka H. Langerhans Cell Histiocytosis of the Clavicle in an Adult: A Case Report and Review of the Literature. Case Rep Oncol. 2015 Oct 16;8(3):426-31. doi: 10.1159/000441415. PMID: 26600774; PMCID: PMC4649755.
  15. Atarbashi Moghadam S, Lotfi A, Piroozhashemi B, Mokhtari S. A Retrospective Analysis of Oral Langerhans Cell Histiocytosis in an Iranian Population: a 20-year Evaluation. J Dent (Shiraz). 2015 Sep;16(3 Suppl):274-277.. PMID: 26535408; PMCID: PMC4623830.
  16. Gavhed D, Laurencikas E, Akefeldt SO, Henter JI. Fifteen years of treatment with intravenous immunoglobulin in central nervous system Langerhans cell histiocytosis. Acta Paediatr. 2011 Jul;100(7):e36-9. doi: 10.1111/j.1651-2227.2010.02125.x. Epub 2011 Jan 11. PMID: 21166862.


Comments


Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable